If North Carolina is able to get a good deal, I dont know why other states wouldnt be able to participate in that. Shortsighted, bad policy In 2023, Connecticut enacted a law requiring Medicaid to cover obesity treatment services
GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro are best known for helping with weight loss and diabetes management, but their benefits extend far beyond that
Do not exceed 4000mg/day
In 2023, Eli Lilly acquired Versanis Bio for $2 billion to obtain Bimagrumab, targeting the emerging fat loss with muscle gain treatment segment
The agency also described generic semaglutide injections as complex synthetic products that are pharmaceutically equivalent to the brand-name reference product
Each mouth-dissolving tablet delivers 500mg of L-glutathione with improved bioavailability, no water needed